OnCo
ideasIdea

Guidelines list the open trials at every decision point, updated monthly

Treatment guidelines tell doctors what to do at each step but rarely which trials are open for that step. Adding a live, monthly-updated list to each decision node would put trials where doctors look.

NCCN, ESMO and national guidelines add a machine-updated 'open trials for this node' panel to each algorithm step, generated from registry data filtered by setting and line of therapy, with a link to slot availability. The static 'clinical trial participation is encouraged' footnote becomes actionable.

Hypothesis
Decision nodes with trial panels will have higher referral rates to the listed trials than nodes without, measured via referral-source tracking at trial sites.
Rationale
Guidelines are the most consulted documents in oncology practice; embedding trials there reaches every clinician without new software.
What would test it
One guideline body pilots panels for two cancers; sites of listed trials record referral source for a year.
Maturity
speculative
Who has to act
research
Cost to try
Small (under $1M)
Years to first evidence
1
Bottlenecks it attacks

Connected

6top

Pages like this

not linked directly; found by shared links